Suppr超能文献

带扩张髂支的主动脉-髂动脉瘤的血管内治疗

Endovascular Treatment of Aorta-Iliac Aneurysms with a Flared Iliac Limb.

作者信息

Duvnjak Stevo, Balezantis Tomas

机构信息

Department of Radiology, Odense University Hospital, Odense C, Denmark.

Department of Clinical Research, University of Southern Denmark, Denmark.

出版信息

Int J Angiol. 2019 Mar;28(1):57-63. doi: 10.1055/s-0039-1683411. Epub 2019 Mar 2.

Abstract

Endovascular abdominal aneurysm repair (EVAR) relies on the quality of the proximal and distal landing zone. Reinterventions are higher in patients with suboptimal landing zone. The study aimed to evaluate reintervention rate after endovascular treatment of an aorta-iliac aneurysm using the flared iliac limbs. The retrospective study included 179 patients treated with EVAR at a single university hospital institution from January 2011 to January 2014 of which 75 patients (42%) were treated with flared iliac limb stent graft and 104 patients (58%) were treated with a nonflared iliac limb stent graft. There were 165 male patients (92%), mean age was 75.8 ± 6.6 years. Thirty-six patients underwent secondary treatment accounting for overall reintervention rate of 20%. Endoleak type 1b occurred in 13 patients (7%), followed by endoleak type 1a in six patients (3%). Endoleak type 2 occurred in seven patients (4%) requiring the treatment due to abdominal aortic aneurysm (AAA) enlargement, endoleak type 3 in three patients (2%), and leg stent graft thrombosis in seven patients (4%). In 143 patients (80%), there were no secondary interventions during the follow-up period. Reintervention due to endoleak type 1b was statistically significantly higher in a flared iliac limb group (  < 0.02) with the rate of 7.2% compared with 1.9% rate in nonflared iliac limb group. The mean follow-up was 44.3 ± 20.4. Overall mortality was 33%. Flared iliac limb with a distal diameter of ≥ 20 mm, show a higher rate of iliac limb reintervention in a follow-up period due to endoleak type 1b.

摘要

血管腔内腹主动脉瘤修复术(EVAR)依赖于近端和远端锚定区的质量。锚定区欠佳的患者再次干预的比例更高。本研究旨在评估使用扩张型髂支的血管腔内治疗主-髂动脉瘤后的再次干预率。这项回顾性研究纳入了2011年1月至2014年1月在一所大学附属医院接受EVAR治疗的179例患者,其中75例(42%)接受了扩张型髂支支架型人工血管治疗,104例(58%)接受了非扩张型髂支支架型人工血管治疗。男性患者165例(92%),平均年龄75.8±6.6岁。36例患者接受了二次治疗,总体再次干预率为20%。1b型内漏发生于13例患者(7%),其次是1a型内漏6例(3%)。2型内漏发生于7例患者(4%),因腹主动脉瘤(AAA)增大需要治疗;3型内漏3例(2%),腿部支架型人工血管血栓形成7例(4%)。143例患者(80%)在随访期间未进行二次干预。扩张型髂支组因1b型内漏进行再次干预在统计学上显著更高(P<0.02),发生率为7.2%,而非扩张型髂支组为1.9%。平均随访时间为44.3±20.4个月。总死亡率为33%。远端直径≥20mm的扩张型髂支在随访期间因1b型内漏导致髂支再次干预的发生率更高。

相似文献

本文引用的文献

4
Displacement Forces in Stent Grafts: Influence of Diameter Variation and Curvature Asymmetry.
Eur J Vasc Endovasc Surg. 2016 Aug;52(2):150-6. doi: 10.1016/j.ejvs.2016.04.014. Epub 2016 Jun 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验